Suppr超能文献

伴有新型突变的甲状腺激素抵抗

Thyroid Hormone Resistance With a Novel Mutation.

作者信息

Khan Kulsum, Moriwala Alak, Siddiqui Zainab

机构信息

Internal Medicine, Nottingham University Hospitals NHS Trust, Nottingham, GBR.

Medicine, S. L. Raheja Hospital, Mumbai, IND.

出版信息

Cureus. 2024 Nov 2;16(11):e72898. doi: 10.7759/cureus.72898. eCollection 2024 Nov.

Abstract

Syndrome of thyroid hormone resistance (THR) is a rare inherited condition characterized by a reduced responsiveness of the tissues to the thyroid hormone. The syndrome is caused primarily by mutations in the thyroid hormone receptor beta (THRB) gene, leading to impaired hormone receptor function. It is a diagnosis of exclusion and often leads to delays in establishing the diagnosis. Management is usually conservative, as over-treating can be unnecessary and potentially detrimental. Our case report aims to highlight the changes in thyroid function tests and the subtle presenting symptoms of this disease so that clinicians are more mindful of this rare condition. It brings to attention the importance of follow-up to monitor the lab values and reach an accurate diagnosis. We also report a novel mutation identified in the THRB gene.

摘要

甲状腺激素抵抗综合征(THR)是一种罕见的遗传性疾病,其特征是组织对甲状腺激素的反应性降低。该综合征主要由甲状腺激素受体β(THRB)基因突变引起,导致激素受体功能受损。这是一种排除性诊断,常常导致诊断延迟。治疗通常较为保守,因为过度治疗可能不必要且有潜在危害。我们的病例报告旨在突出甲状腺功能检查的变化以及该疾病细微的表现症状,以便临床医生更加关注这种罕见病症。它提醒人们注意随访监测实验室值以获得准确诊断的重要性。我们还报告了在THRB基因中鉴定出的一种新突变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验